Chao Tung Wen
Direktor/Vorstandsmitglied bei TATUNG SYSTEM TECHNOLOGIES INC.
Aktive Positionen von Chao Tung Wen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TATUNG SYSTEM TECHNOLOGIES INC. | Direktor/Vorstandsmitglied | 24.06.2013 | - |
| Independent Dir/Board Member | 24.06.2013 | - | |
| National Chengchi University | Corporate Officer/Principal | - | - |
Karriereverlauf von Chao Tung Wen
Ehemalige bekannte Positionen von Chao Tung Wen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| E INK HOLDINGS INC. | Direktor/Vorstandsmitglied | 18.06.2014 | - |
| Independent Dir/Board Member | 18.06.2014 | - | |
| Eastern Ad | Vorsitzender | - | - |
| PHARMADAX INC. | Direktor/Vorstandsmitglied | 27.09.2013 | - |
| Independent Dir/Board Member | 27.09.2013 | - |
Ausbildung von Chao Tung Wen
| Tunghai University | Undergraduate Degree |
| Rochester Christian University | Masters Business Admin |
| Rensselaer Polytechnic Institute | Doctorate Degree |
Statistik
International
| Taiwan | 7 |
| Vereinigte Staaten | 3 |
Operativ
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 5 |
| Commercial Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| TATUNG SYSTEM TECHNOLOGIES INC. | Commercial Services |
| E INK HOLDINGS INC. | Electronic Technology |
| Private Unternehmen | 2 |
|---|---|
PharmaDax Inc.
 PharmaDax Inc. Pharmaceuticals: MajorHealth Technology PharmaDax Inc. engages in the development and marketing of generic dossiers. Its products include Glyburide, Quetiapine Fumarate ER, and Metoprolol Succinate ER tablets. The company was founded by Yi Pin Huang on March 21, 2008 and is headquartered in New Taipei, Taiwan. | Health Technology |
| Eastern Ad |
- Börse
- Insiders
- Chao Tung Wen
- Erfahrung
